Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The Personalized Medicine Opportunity

This article was originally published in Start Up

Executive Summary

Personalized medicine is a field as vast as the differences between individuals, and encompasses technologies, markets, and treatment strategies ranging from autologous cancer vaccines to molecular diagnostics and gene-targeted drugs to methods for visualizing subtle differences in tissues--the foci of the three companies profiled herein.
Advertisement

Related Content

Aureon Biosciences
Favrille Inc.
Xanthus Life Sciences Inc.
Pharmacogenomic Data and Labeling: A Less-Safe Harbor for Existing Drugs?
Pharmacogenomic Data and Labeling: A Less-Safe Harbor for Existing Drugs?
PDUFA Extension Adds More than Funding
PDUFA Extension Adds More than Funding
The Bricks and Mortar of Personalized Medicine
The Bricks and Mortar of Personalized Medicine

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC090772

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel